IX MOLECULAR
CYTOPATHOLOGY
ACROSS THE OCEAN
VIRTUAL MEETING
3rd / 4th DECEMBER 2020
Organized by
Giancarlo Troncone
Sinchita Roy-Chowdhuri
Maria D. Lozano
Organizing Secretariat
Concerto Srl
Tel + 39 081.19569195
E-mail: info@concertosrl.net
With the Patronage of:
Selected Highlights from “The IX Molecular Cytopathology Meeting”
Because of COVID-19 and keeping the health and safety of our attendees as our top priority, this year’s annual meeting will be delivered in a virtual format.
For the past several years, the International Molecular Cytopathology Meeting held annually in Naples, Italy, has focused on providing a perspective on the evolution of molecular pathology in the field of cytopathology with updates on cytological and molecular classifications. This year with the virtual format of the Ninth Molecular Cytopathology Meeting, we are aiming to provide a more diverse and international perspective to the practice of molecular cytopathology with participation from across the world.
The meeting will be held as two half-day sessions, a morning session in the US that will correspond to an afternoon session in Europe, to allow maximum participation from most countries.
Day 1 of the meeting will feature sessions on Thyroid, Pancreatobiliary, Salivary Gland, Lung and and a special session on COVID-19;
Day 2 will feature sessions on Cervical cytology, Urine, Serous Fluid and Breast, Immunocytochemistry.
Each session will be introduced by a Moderator presenting an update on the cytological classification followed by one or two presentations on the molecular updates on the same topic. Each session will be followed by an interactive discussion session, including the moderator and speakers, responding to and discussing questions and comments from the global audience. With the virtual format, we are hoping for a novel and unique way to make this meeting as interactive as possible and give the audience a chance to engage with the speakers.
PROGRAM
Program according to CET (Central European Time)
Pacific Time (PT): Los Angeles -9 hrs
Central Time (CT): Chicago -7 hrs
Eastern Time (ET): New York -6 hrs
3rd DECEMBER 2020
INTRODUCTION
2.30 PM Introduction to IX MOLECULAR CYTOPATHOLOGY ACROSS THE OCEAN
Giancarlo Troncone
Sinchita Roy-Chowdhuri
Maria D. Lozano
SESSION I: COVID-19 session
2.50 PM Introduction: Epidemic implication for Molecular Cytopathology
G. Troncone
3.10 PM Cytology in the Time of Coronavirus Disease (covid-19): An Italian Perspective
E. Vigliar
SESSION II: Molecular Thyroid Cytopathology
3.30 PM Introduction: The indeterminate thyroid cytopathology: what’s new from TBSRTC, second edition
Z.W. Baloch
3.50 PM Molecular Cytopathology for Thyroid Nodules: A Review of Methodology and Test Performance
M. Nishino
4.10 PM Interventional molecular thyroid cytopathology. From the FNA to the NGS at the University Federico II of Naples
C. Bellevicine
4.30 PM Questions & Answers
SESSION III: Molecular Pancreatobiliary Cytopathology
4.40 PM Introduction: Standardized Terminology and Nomenclature for Pancreatobiliary Cytology: The Papanicolaou Society of Cytopathology Guidelines
L.J. Layfield
5.00 PM Guidelines for Pancreaticobiliary Cytology from the Papanicolaou Society of Cytopathology: the contribution of molecular tests
M. Pitman
5.20 PM Questions & Answers
SESSION IV: Ancillary Testing in Salivary Gland Cytology
5.30 PM Introduction: The Milan System for Reporting Salivary Gland Cytopathology: Considerations From Theory to Practice
E.D. Rossi
5.50 PM The place for molecular tests in the Milan System for Reporting Salivary Gland Cytopathology
W.C. Faquin
6.00 PM Questions & Answers
SESSION V: Lung
6.10 PM Introduction: Collection and Handling of Thoracic Small Biopsy and Cytology Specimens for Ancillary Studies: Guideline from American College of Pathologists
S. Roy-Chowdhuri
6.30 PM What is new in lung biomarker testing: implication for cytology and liquid biopsy specimens
P. Hofman
6.50 PM Challenges and Opportunities of cfDNA Analysis Implementation in Clinical Practice: focus on lung cancer
U. Malapelle
7.10 PM Questions & Answers
4th DECEMBER 2020
SESSION I: Cervical cytology
2.30 PM Introduction: Cervical Cytology in the era of molecular screening
G. Negri
2.50 PM The 2019 ASCCP Risk management guidelines for cervical cancer screening
R. Nayar
3.10 PM Questions & Answers
SESSION II: Ancillary testing in urine cytology
3.20 PM Introduction: The Paris System for Reporting Urine Cytology: Considerations From Theory to Practice
G.A. Barkan
3.40 PM UroVysion® FISH Assay and risk-stratification using the Paris System for Reporting Urine Cytology
E.M. Wojcik
3.50 PM Questions & Answers
SESSION III: Serous fluid cytopathology
4.00 PM Introduction: Development of the International System for Reporting Serous Fluid Cytopathology
A. Chandra
4.20 PM Toward the International System for Reporting Serous Fluid Cytopathology: how to incorporate molecular data in our cytopathology reports
F.C. Schmitt
4.40 PM Questions & Answers
SESSION IV: Breast cytology
4.50 PM Introduction: The International Academy of Cytology Yokohama System for Reporting Breast FNAB: Introduction and Overview
P. Vielh
5.10 PM A tale of two needles. Core- versus fine-needle in the era of molecular cytopathology
F.C. Schmitt
5.30 PM Questions & Answers
SESSION V: Immunocytochemistry
5.40 PM Introduction and Moderator
L. Bubendorf
6.00 PM Comprehensive predictive testing (NGS and ICC) on Pap-stained cytology
S. Savic
6.20 PM Challenges of ICC and FISH in the field of targeted therapies. From cell block to smears
M.D. Lozano
6.40 PM Questions & Answers
7.00 PM Closing remarks
FACULTY
Zubair W. Baloch
MD, PhD
Philadelphia, Pennsylvania – USA
Professor of Pathology and Laboratory Medicine
University of Pennsylvania Medical Center- Perelman School of Medicine
Güliz A. Barkan
MD, FIAC
Maywood, Illinois – USA
Professor of Pathology and Urology
Vice Chair of Education Cytopathology Fellowship Program Director
Director of Cytopathology Loyola University Healthcare System
Claudio Bellevicine
MD, PhD
Naples – Italy
Assistant Professor of Anatomic Pathology,
Department of Public Health, University of Naples Federico II
Lukas Bubendorf
MD
Basel – Switzerland
Professor, Institute of Pathology
University Hospital Basel
Ashish Chandra
MD, FRCPath, DipRCPath (Cytol)
London – United Kingdom
Consultant Pathologist Lead for Cytopathology & Urological Histopathology
St Thomas’ hospital London
William C. Faquin
MD, PhD
Boston, Massachusetts – USA
Professor of Pathology,
Harvard Medical School & Massachusetts General Hospital
Paul Hofman
MD, PhD
Nice – France
Professor of Pathology, Laboratory of Clinical and Experimental Pathology
University Côte d’Azur, Nice
Lester J. Layfield
MD
Columbia, Missouri – USA
Medical Student Coordinator, OSA IVPathology and Anatomical Sciences Dept. University of Missouri
Maria D. Lozano
MD, PhD, MIAC
Pamplona – Spain
Professor of Pathology, Director Department Of Pathology
Clinica University of Navarra
Umberto Malapelle
PhD
Naples – Italy
Chief Supervisor of Predictive Molecular Pathology Lab, Department of Public Health, University of Naples Federico II
Ritu Nayar
MD
Chicago, Illinois – USA
Professor of Pathology and Medical Education
Vice Chair for Education and Faculty Development, Department of Pathology Northwestern University, Feinberg School of Medicine, Chicago
Giovanni Negri
MD, PhD, MIAC
Bolzano – Italy
Pathology Unit Central Hospital Bolzano
Michiya Nishino
MD, PhD
Boston, Massachusetts – USA
Director, Head&Neck Pathology Beth Israel Deaconess Medical Center
Assistant Professor of Pathology Harvard Medical School
Martha Pitman
MD
Boston, Massachusetts – USA
Professor of Pathology Harvard Medical School
Esther D. Rossi
MD, PhD
Rome, Italy
Aggregate professor of Anatomic Pathology
Fondazione Policlinico Universitario Agostino Gemelli. IRCCS
Sinchita Roy-Chowdhuri
MD, PhD
Houston ,Texas – USA
Assistant Professor Department of Pathology, UT M.D. Anderson Cancer Center
Spasenija Savic Prince
MD – Pathology (FMH) Cytopathology
Basel – Switzerland
Senior pathologist, Institute for Medical Genetics and Pathology University Hospital Basel
Fernando C. Schmitt
MD, PhD, FIAC, IFCAP
Porto – Portugal
Professor of Pathology at Medical Faculty of Porto University Head, Molecular Pathology Unit, IPATIMUP, General Secretary of the International Academy of Cytology, President of the International Society of Breast Pathology
Giancarlo Troncone
MD, PhD
Naples – Italy
Full Professor of Anatomic Pathology, Department of Public Health, University of Naples Federico II
Philippe Vielh
MD, PhD, FIAC
Paris – France
Medipath and American Hospital of Paris
Elena Vigliar
MD, PhD
Naples – Italy
Assistant Professor of Anatomic Pathology, Department of Public Health, University of Naples Federico II
Eva M. Wojcik
MD
Maywood, Illinois – USA
Professor and Chair, Department of Pathology and Laboratory Medicine Loyola University Medical Center
